Longitudinal evaluation of anthracycline cardiotoxicity by signal-averaged electrocardiography in children with cancer

Pediatrics International

Volumn 44, Issue 2, 2002, Pages 134-140

  Fukumi, Daichi ^a,b   Uchikoba, Yohko ^a   Maeda, Miho ^a   Ogawa, Shunichi ^a  

^a NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Anthracycline cardiotoxicity; Cancer; Children; Signal averaged electrocardiography

Indexed keywords

ACLARUBICIN; ANTHRACYCLINE; DAUNORUBICIN; DOXORUBICIN; EPIRUBICIN; MITOXANTRONE; PIRARUBICIN;

ADOLESCENT; ARTICLE; CALCULATION; CANCER DIAGNOSIS; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART DISEASE; HEART FAILURE; HOLTER MONITORING; HUMAN; INFANT; LONGITUDINAL STUDY; MALE; PRIORITY JOURNAL; SIGNAL AVERAGED ELECTROCARDIOGRAPHY;

ANTHRACYCLINES; CARDIOMYOPATHIES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; LONGITUDINAL STUDIES; MALE; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 0036119213     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1328-8067.2001.01526.x     Document Type: Article

References (35)

1. Risk factors for doxorubicin-induced congestive heart failure
2. Doxorubicin-induced cardiac toxicity
3. Adriamycine (NSC-123127) cardiomyopathy - An overview with determination of risk factors
4. Cardiotoxity in children treated with anthracyclines
5. Cardiomyopathy induced by anthracycline derivatives
6. Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients
7. Echocardiographic assessment of anthracycline cardiotoxicity in children
8. 123I-BMIPP imaging
9. Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: Autonomic versus echocardiographic variables
10. Early detection of anthracycline-induced cardiotoxicity by radionuclide angiocardiography
11. QT dispersion and late potentials during doxorubicin therapy for non-Hodgkin's lymphoma
12. Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction
13. Independent value of signal-averaged electrocardiography and left ventricular function in identifying patients with sustained ventricular tachycardia with coronary artery disease
14. Value of the signal-averaged electrocardiogram as a predictor of sudden death in myocardial infarction and dilated cardiomyopathy
15. Evaluation of myocardial ischemia and infarction by signal-averaged electrocardiographic late potentials in children with Kawasaki disease
16. Early detection of Anthracycline cardiotoxity by signal-averaged electrocardiographic late potentials in children with acute leukemia
17. Longitudinal evaluation of Anthracycline cardiotoxity by signal-averaged electrocardiographic late potentials in children with cancer
18. Cardiac function in sickle cell anemia
19. Cardiovascular function before and after iron therapy by echocardiography in patients with iron deficiency anemia
20. Cardiac ultrastructual changes induced by daunorubicin therapy
21. Free radical-dependent DNA lesions are involved in the delayed cardiotoxity induced by adriamycin in the rat
22. Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in the rats
23. Inhibition of sodium-potassium activated adenocine 5′-triphospatase and ion transport by adriamycin
24. Adriamycin stimulated low-affinity Ca2+ binding and lipid peroxidation but depress myocardial function
25. Direct effects of adriamycin on the rat heart sarcolemmina
26. Effect of anthracycline antibiotics on oxygen radical formation in rat heart
27. Sub-cellular effects of adriamycin in the heart: A concise review
28. Induction of apoptosis in chronic myogenous leukemia lymphocytes by hydroxyurea and adriamycin
29. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion
30. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
31. Anthracycline-induced cardiotoxicity in children with malignancies
32. Formation of binucleated myocardial cells in the neonatal rat: An index for growth hypertrophy
33. Myocardial cell growth and blood pressure development in neonatal spontaneously hypertensive rats
34. Pulmonary antioxidant enzyme maturation in the fetal and neonatal rat: 1. Developmental profiles
35. The development of antioxidant enzymatic defence in the perinatal rat lung: Activities of superoxide dismutase, glutathione peroxidase and catalase